Bank of New York Mellon »

Cartesian Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $243k 15k 16.12
2024-06-30 $538k 20k 27.01